English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Nitric oxide and dopamine neurons: implications for Parkinson´s disease

Mena, M., Casarejos, M., & Canals, S. (2005). Nitric oxide and dopamine neurons: implications for Parkinson´s disease. Current Medicinal Chemistry, 5(3), 193-205. doi:10.2174/1568015054863846.

Item is

Files

show Files

Locators

show
hide
Locator:
http://www.eurekaselect.com/90137/article (Publisher version)
Description:
-

Creators

show
hide
 Creators:
Mena, MA, Author
Casarejos, MJ, Author
Canals, S1, Author              
Affiliations:
1External Organizations, ou_persistent22              

Content

show
hide
Free keywords: -
 Abstract: There is evidence suggesting that nitric oxide (NO) may play an important role in dopamine (DA) cell death. NO may act as a neuroprotector or neurotoxic agent in dopamine neurons, depending on cell redox status. Glutathione (GSH) depletion is the earliest biochemical alteration shown to date in brains of Parkinson‘s disease (PD) patients. However, data from animal models show that GSH depletion by itself is not sufficient to induce nigral degeneration. Low NO concentrations have neurotrophic effects on DA cells via a cGMP-independent mechanism that may implicate up-regulation of GSH. On the other hand, higher levels of NO induce cell death in both DA neurons and mature oligodendrocytes that is totally reverted by soluble factors released from glia. Alterations in GSH levels change the neurotrophic effects of NO in dopamine function into neurotoxic, under these conditions, NO triggers a programmed cell death with markers of both apoptosis and necrosis characterised by an early production o f free radicals followed by late activation of the sGC/cGMP/PKG pathway. Arachidonic acid metabolism through the 12-lipoxygenase (12-LOX) pathway is also central for this GSH-NO interaction. Neurotrophism of NO switches into neurotoxicity after GSH depletion, due to persistent activation of the ERK-1/2 signaling pathway in glial cells. The implication of these cell death signaling pathways in pathological conditions like Parkinson‘s disease, where GSH depletion, glial dysfunction and NO overproduction have been documented, are discussed.

Details

show
hide
Language(s):
 Dates: 2005-09
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Identifiers: DOI: 10.2174/1568015054863846
BibTex Citekey: 3373
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Current Medicinal Chemistry
  Other : Curr. Med. Chem.
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: Schiphol, The Netherlands : Bentham Science Publishers
Pages: - Volume / Issue: 5 (3) Sequence Number: - Start / End Page: 193 - 205 Identifier: ISSN: 0929-8673
CoNE: https://pure.mpg.de/cone/journals/resource/954925568793